BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 15, 2025
See today's BioWorld
Home
» OIG: CMS is leaving millions in savings on Part B drugs on the table
To read the full story,
subscribe
or
sign in
.
OIG: CMS is leaving millions in savings on Part B drugs on the table
Aug. 22, 2019
By
Mari Serebrov
It wouldn't take an act of the U.S. Congress or even an executive order for the Centers for Medicare & Medicaid Services (CMS) to save millions of dollars on Medicare Part B drugs.
BioWorld